These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 540479

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. [Indications for and the therapeutic action of hypolipidemic agents in patients with hyperlipoproteinemias].
    Goranov I, Naumova R, Kerekovska M, Balabanski L.
    Vutr Boles; 1987; 26(1):96-101. PubMed ID: 3590738
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. [Current dietetic and pharmacological treatment of hyperlipoproteinemia].
    Caruzzo C.
    Minerva Med; 1975 Dec 08; 66(84):4527-34. PubMed ID: 1105243
    [Abstract] [Full Text] [Related]

  • 48. [Clinical trials with Fonlipol. Apropos of 50 cases].
    Warembourg H, Jaillard J.
    Lille Med; 1974 Apr 08; 19(4 Suppl 11):528-31. PubMed ID: 4612282
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. [Effect of phenofibrate on the blood serum lipid level in hyperlipoproteinemias and its comparison with clofibrate].
    Sznajderman M.
    Pol Arch Med Wewn; 1980 Jun 08; 63(6):543-9. PubMed ID: 7402954
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Fenofibrate-induced myopathy.
    Ghosh B, Sengupta S, Bhattacharjee B, Majumder A, Sarkar SB.
    Neurol India; 2004 Jun 08; 52(2):268-9. PubMed ID: 15269493
    [Abstract] [Full Text] [Related]

  • 53. [Diabetic nephropathy, hypothyroidism and colfibrate-induced myopathy (author's transl)].
    Rumpf KW, Quellhrost E, Scheler F.
    Med Klin; 1976 Nov 12; 71(46):2023-7. PubMed ID: 995042
    [Abstract] [Full Text] [Related]

  • 54. [Effect of bezafibrate on lipid and apoprotein levels in patients with idiopathic hypertriglyceridemia].
    Naruszewicz M, Nowicka G, Szostak WB, Kłosiewicz-Latoszek L.
    Kardiol Pol; 1982 Nov 12; 25(7-8):527-31. PubMed ID: 7169740
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Pirifibrate in the treatment of hyperlipoproteinemias: a multicenter study.
    Domingo AJ, Gutiérrez JA, Menéndez JA, Micó L, Muñoz M, de Oya M.
    Clin Ther; 1980 Nov 12; 3(3):219-26. PubMed ID: 7459931
    [Abstract] [Full Text] [Related]

  • 59. Pharmacologic therapy for the hyperlipidemic patient.
    Hunninghake DB.
    Am J Med; 1983 May 23; 74(5A):19-22. PubMed ID: 6846378
    [Abstract] [Full Text] [Related]

  • 60. The efficacy of lipid lowering drugs alone and in combination.
    Hansen PF.
    Postgrad Med J; 1975 May 23; 51(8):63-5. PubMed ID: 768949
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.